Title:
METHODS FOR DOSING AND TREATMENT WITH A COMBINATION OF A CHECKPOINT INHIBITOR THERAPY AND A CAR T CELL THERAPY
Document Type and Number:
WIPO Patent Application WO/2022/212400
Kind Code:
A8
Abstract:
Provided herein are methods and uses of combination therapies involving a T cell therapy, e.g., a CAR T cell therapy, and a checkpoint inhibitor therapy, e.g. an anti-PD-1 antibody and/or an anti-LAG3 antibody, for treating subjects with cancers such as lymphomas, and related methods, uses, and articles of manufacture.
More Like This:
Inventors:
TREDE NIKOLAUS SEBASTIAN (US)
SURYAWANSHI SATYENDRA (US)
AGRAWAL SHRUTI (US)
SRIVASTAVA SHIVANI (US)
PULHAM TIM (CH)
DESTEFANO JOE (US)
BRAND NICOLAS (CH)
DUBOWY RONALD (US)
SURYAWANSHI SATYENDRA (US)
AGRAWAL SHRUTI (US)
SRIVASTAVA SHIVANI (US)
PULHAM TIM (CH)
DESTEFANO JOE (US)
BRAND NICOLAS (CH)
DUBOWY RONALD (US)
Application Number:
PCT/US2022/022377
Publication Date:
November 02, 2023
Filing Date:
March 29, 2022
Export Citation:
Assignee:
JUNO THERAPEUTICS INC (US)
International Classes:
A61K39/00; A61P35/00; C07K14/705; C07K14/725; C07K16/28
Attorney, Agent or Firm:
RICE, Rachel et al. (US)
Download PDF: